Matthew Strobeck, Director at Accelerate Diagnostics, Inc (AXDX), bought 30,000 shares at $7.11 ($71K) on 2020-03-18, disclosed to the SEC on 2020-03-20.
Open-market purchase of $71k AXDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 20,000 | $0 | 0.0% |
| 2 | $7.11 | 10,000 | $71K | 100.0% |
| Total | $2.37 avg | 30,000 | $71K | 100% |
| Filing → |
| AZYO | BUY | 2023-02-13 | $398K | — | Filing → |
| BDSX | BUY | 2022-11-21 | $5.4M | — | Filing → |
| BDSX | BUY | 2022-04-11 | $2.0M | — | Filing → |